'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)

被引:28
作者
Jefferson, MF
Pendleton, N
Faragher, EB
Dixon, GR
Myskow, MW
Horan, MA
机构
[1] UNIV S MANCHESTER HOSP, DEPT GERIATR MED, MANCHESTER M20 2LR, LANCS, ENGLAND
[2] UNIV S MANCHESTER HOSP, DEPT MED STAT, MANCHESTER M20 2LR, LANCS, ENGLAND
[3] BROADGREEN HOSP, DEPT HISTOPATHOL, LIVERPOOL L14 8HX, MERSEYSIDE, ENGLAND
关键词
lung cancer; 'tumour volume'; prognosis; survival;
D O I
10.1038/bjc.1996.381
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many factors have been individually related to outcome in populations of non-small-cell lung cancer (NSCLC) patients. Factors responsible for the outcome of an individual after surgical resection are poorly understood. We have examined the importance of 'tumour volume' in determining prognosis of patients following resection of NSCLC in a multivariate model. Cox's proportional hazard analysis was used to determine the relative prognostic significance of stage, patient age, gender, tumour cell-type, nodal score and estimated 'tumour volume' in 669 cases with NSCLC treated with surgical resection, of which 280 had died. All factors (except tumour cell-type, P=0.33) were individually related to survival (P<0.05). When examined together, survival time was significantly and independently related to 'tumour volume' and stage (P<0.001), and other factors ceased to be significant. In cases with stage I or II rumours, risk of death was found to increase significantly with increasing estimated 'tumour volume' (23.8% relative increase in hazard of death per doubling of 'tumour volume', 95% confidence interval 13.2-35.2%, P<0.001 stage I; P<0.006 stage II). In cases with stage IIIa tumours this factor alone was the significant prognostic variable. In conclusion, an estimate of 'tumour volume' significantly improves prediction of prognosis for individual NSCLC patients with UICC stage I or II tumours.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 25 条
[1]   DETERMINANTS OF IMPROVED OUTCOME IN SMALL-CELL LUNG-CANCER - AN ANALYSIS OF THE 2,580-PATIENT SOUTHWEST ONCOLOGY GROUP DATA-BASE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1563-1574
[2]  
[Anonymous], 1982, Am J Clin Pathol, V77, P123
[3]  
CARNEY D N, 1992, Current Opinion in Oncology, V4, P292, DOI 10.1097/00001622-199204000-00010
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
GREENBERG SD, 1987, PATHOL ANNU, V22, P387
[6]  
GRONOWITZ JS, 1990, CANCER, V66, P722, DOI 10.1002/1097-0142(19900815)66:4<722::AID-CNCR2820660421>3.0.CO
[7]  
2-J
[8]  
Hermanek P., 1987, TNM Classification of Malignant Tumors, V4th edn
[9]  
HUMPHREY EW, 1990, J THORAC CARDIOV SUR, V100, P837
[10]   LUNG-CANCER SURGERY - A CRITICAL-REVIEW OF THE EVIDENCE [J].
LEDERLE, FA ;
NIEWOEHNER, DE .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (21) :2397-2400